巴西领先的医学教育集团Afya Limited（纳斯达克股票代码：AFYA）今日盘中股价大涨5.09%，投资者对公司发布的2025年第二季度及上半年强劲财务业绩反应积极。
根据公司公告，Afya在2025年第二季度实现了显著增长。收入同比增长13.5%至9.194亿雷亚尔，调整后EBITDA同比增长16.6%至4.008亿雷亚尔，调整后EBITDA利润率扩大至43.6%。值得注意的是，公司2025年上半年业绩更为亮眼，收入同比增长15.0%，调整后EBITDA大幅增长20.4%，利润率提升至48.1%。此外，公司保持了强劲的现金创造能力，经营现金转换比率达到88.8%。
除了强劲的财务表现，Afya还宣布了几项积极的战略举措。公司重申了2025年全年业绩指引，显示出管理层对未来业绩的信心。董事会批准了一项新的股份回购计划，授权回购最多400万股A类股份，这一举措可能进一步提振投资者信心。此外，公司最近完成了对FUNIC的收购，扩大了其在巴西米纳斯吉拉斯州的业务布局，新增60个医学席位。这些因素综合推动了Afya股价的显著上涨，反映了市场对公司业务增长和战略执行的积极评价。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.